May 14, 2020 — Modern clinical trials distribute samples to an expanding range of screening labs, specialty labs, and bio-banking facilities. Maintaining visibility into sample collection and data processing too often requires manually comparing inventories from each lab’s LIMS, and then checking against what is expected according to the protocol.
Join us to learn how industry leaders leverage technology to quickly and efficiently develop virtual master sample inventories – in many cases, by deploying smart algorithms against information they already have on hand.
You’ll see how this approach enables:
- Rapid identification of discrepancies in expected vs. actual sample collection status as well as discrepancies across sites and/or labs
- Alerting of sample quality or site performance gaps before it’s too late to intervene
- Automated dashboard creation for broad visibility across a clinical trial team
- And much more!
